heXem bio

Los Angeles, United States

HexemBio develops a synthetic human Yolk Sac platform to rejuvenate blood stem cells to extend healthy lifespan.

$10.4M raised

Mar 2026

Seed

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has heXem bio raised?

heXem bio has raised $10.4M in total funding. The most recent round was Seed. The last funding was announced in March 2026.

Who are heXem bio's investors?

heXem bio's investors include Gaingels, Alumni Ventures, Draper Associates, Seraphim Space, ZAKA VC.

Where is heXem bio headquartered?

heXem bio is headquartered in Los Angeles, United States.

What does heXem bio do?

HexemBio develops a synthetic human Yolk Sac platform to rejuvenate blood stem cells to extend healthy lifespan.

What stage is heXem bio at?

heXem bio is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated March 28, 2026.

MLA

"heXem bio — Funding & Investors." VCBacked, March 28, 2026, https://www.vcbacked.co/company/hexem-bio. Accessed July 1, 2026.

APA

VCBacked. (2026). heXem bio — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/hexem-bio

Wikipedia (cite web)

{{cite web |title=heXem bio — Funding & Investors |url=https://www.vcbacked.co/company/hexem-bio |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated March 28, 2026.